IRIS
CHITI, ARTURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.138
AS - Asia 7.611
EU - Europa 2.944
SA - Sud America 1.256
AF - Africa 482
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 12
Totale 27.458
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.818
SG - Singapore 4.801
CN - Cina 1.134
BR - Brasile 1.032
DE - Germania 736
VN - Vietnam 724
FI - Finlandia 552
IE - Irlanda 403
NG - Nigeria 349
IT - Italia 249
FR - Francia 232
IN - India 214
CA - Canada 211
HK - Hong Kong 174
GB - Regno Unito 163
SE - Svezia 136
NL - Olanda 135
TR - Turchia 111
AR - Argentina 86
RU - Federazione Russa 75
BD - Bangladesh 68
IQ - Iraq 66
MX - Messico 64
IL - Israele 62
BE - Belgio 59
PL - Polonia 45
ZA - Sudafrica 39
EC - Ecuador 30
CL - Cile 29
PK - Pakistan 29
ES - Italia 28
JP - Giappone 25
UA - Ucraina 25
ID - Indonesia 23
CO - Colombia 20
MA - Marocco 20
SA - Arabia Saudita 20
VE - Venezuela 19
AT - Austria 16
TN - Tunisia 16
KE - Kenya 15
PH - Filippine 15
AE - Emirati Arabi Uniti 14
IR - Iran 14
PY - Paraguay 14
KG - Kirghizistan 13
JM - Giamaica 12
JO - Giordania 12
KZ - Kazakistan 12
NP - Nepal 12
PE - Perù 12
CZ - Repubblica Ceca 11
EG - Egitto 10
MY - Malesia 10
AZ - Azerbaigian 9
UY - Uruguay 9
AU - Australia 8
ET - Etiopia 8
EU - Europa 8
LT - Lituania 8
RO - Romania 8
TW - Taiwan 8
UZ - Uzbekistan 8
PA - Panama 7
CH - Svizzera 6
DZ - Algeria 6
DO - Repubblica Dominicana 5
EE - Estonia 5
HR - Croazia 5
LB - Libano 5
PT - Portogallo 5
SN - Senegal 5
BY - Bielorussia 4
CR - Costa Rica 4
GT - Guatemala 4
HN - Honduras 4
MD - Moldavia 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
SY - Repubblica araba siriana 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
AO - Angola 3
BG - Bulgaria 3
BO - Bolivia 3
GR - Grecia 3
KR - Corea 3
LV - Lettonia 3
MN - Mongolia 3
MT - Malta 3
OM - Oman 3
PS - Palestinian Territory 3
RS - Serbia 3
TH - Thailandia 3
AM - Armenia 2
BH - Bahrain 2
CI - Costa d'Avorio 2
DK - Danimarca 2
HU - Ungheria 2
Totale 27.425
Salva come PNG Salva come JPEG
Città #
Singapore 2.273
Dallas 2.224
Wilmington 2.010
Chandler 1.882
Ashburn 840
San Mateo 776
The Dalles 728
Ann Arbor 609
Helsinki 547
Shanghai 531
Falkenstein 448
Dublin 401
Leawood 401
San Jose 388
Boardman 357
Benin City 348
Lawrence 327
Princeton 327
Beijing 272
Ho Chi Minh City 247
New York 230
Fairfield 195
Woodbridge 181
Toronto 171
Paris 169
Hanoi 165
Hong Kong 139
Amsterdam 118
Pune 99
London 88
São Paulo 87
Milan 84
Kocaeli 80
Los Angeles 79
Seattle 75
Santa Clara 62
Brussels 57
San Diego 57
Norwalk 49
Da Nang 48
Monmouth Junction 44
Rio de Janeiro 44
Warsaw 40
Munich 35
Council Bluffs 34
Moscow 33
Phoenix 32
Brooklyn 31
Falls Church 30
Orem 29
Hillsboro 25
Chennai 24
Haiphong 24
Houston 24
Belo Horizonte 23
Johannesburg 23
Baghdad 19
Campinas 18
Montreal 18
Atlanta 17
Hải Dương 17
Mumbai 16
Tokyo 16
Bến Tre 15
Dhaka 15
Redmond 15
San Francisco 15
Stockholm 15
Brasília 14
Curitiba 14
Redwood City 14
Boston 13
Goiânia 13
Guayaquil 13
Mexico City 13
Osasco 13
Porto Alegre 13
Santiago 13
Chicago 12
Denver 12
Frankfurt am Main 12
Nairobi 12
Bishkek 11
Cambridge 11
Des Moines 11
Erbil 11
Guarulhos 11
Naples 11
Reston 11
Amman 10
Berlin 10
Buffalo 10
Can Tho 10
Kingston 10
Riyadh 10
Vienna 10
Zhengzhou 10
Ankara 9
Columbus 9
Fortaleza 9
Totale 19.225
Salva come PNG Salva come JPEG
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 745
111In-octreotide uptake in granulomatous and tumor lesions in a patient with small-cell lung cancer 718
111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer. 694
11Cl-choline PET/CT in imaging locally advanced prostate cancer 679
18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy 156
18F-FDG pet does not improve contrast enhanced CT scan sensitivity in the evaluation of liver metastases after chemotherapy 148
Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery 124
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 123
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 123
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 121
A portrait of the scientist as a young woman Comments after the first EANM Young Investigators' Meeting 120
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 120
Applications of PET imaging with radiolabelled choline (C-11/F-18-choline) 119
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis 116
[F-18] FDG PET/CT features for the molecular characterization of primary breast tumors 116
A case of metastatic axillary lymph nodes involvement from unknown primary cancer: Clinical usefulness of [Tc-99m]-sestamibi 116
Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement 115
F-18-DOPA PET/CT in Neuroblastoma Comparison of Conventional Imaging With CT/MR 105
Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy 105
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 103
A DOUBTFUL IMAGE OF LEVEEN SHUNT PATENCY 102
INDIUM-111-DTPA-OCTREOTIDE SCINTIGRAPHY MODULATION BY TREATMENT WITH UNLABELED SOMATOSTATIN ANALOG IN SMALL-CELL LUNG-CANCER 100
Correlation of microvascular fractal dimension with positron emission tomography [C-11]-methionine uptake in glioblastoma multiforme: Preliminary findings 100
Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy 100
Procedure guidelines for PET/CT tumour imaging with Ga-68-DOTA-conjugated peptides: Ga-68-DOTA-TOC, Ga-68-DOTA-NOC, Ga-68-DOTA-TATE 99
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery 98
I-131/I-123-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging 98
A case of atypical giant cell arteritis diagnosed by positron emission tomography (PET) 98
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma 98
A risk management approach for imaging biomarker-driven clinical trials in oncology 98
High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant 97
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 97
Role of I-131-metaiodobenzylguanidine (MIBG) in the treatment of neuroendocrine tumours - Experience of the National Cancer Institute of Milan 96
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 95
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 95
Guideline for PET/CT imaging of neuroendocrine neoplasms with Ga-68-DOTA-conjugated somatostatin receptor targeting peptides and F-18-DOPA 94
[C-11] Choline PET/CT Impacts Treatment Decision Making in Patients With Prostate Cancer Referred for Radiotherapy 94
Diffusion-weighted imaging and loco-regional N staging of patients with colorectal liver metastases 93
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI 93
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 93
Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticals 92
Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer: Can positron emission tomography (PET) with F-18-FDG be considered as the best method? 92
Clinical implications of immunohistochemical assessment of somatostatin receptors subtype 2 and 5 in the diagnostic and therapeutic management of gastro-entero-pancreatic neuroendocrine tumours 92
Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography 92
C-11-Methionine uptake in secondary brain epilepsy 90
Exploration of Disease Markers under Translational Medicine Model 90
Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer 90
[F-18]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria 90
Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning 90
Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail 89
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems 89
Role of C-11-choline PET/CT in radiation therapy planning of patients with prostate cancer 89
Bone lesion in a patient with transplanted liver for a metastatic carcinoid. The role of somatostatin receptor scintigraphy 89
A method to reduce acetonitrile amount in F-18-FDG synthesis 89
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 89
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 89
PREDICTIVE VALUE OF EARLY PET DURING SALVAGE CHEMOTHERAPY IN RELAPSING/REFRACTORY HODGKIN'S LYMPHOMA (HL) PATIENTS 88
EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma 88
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy 87
Assessment of tumor response in malignant pleural mesothelioma 87
Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [F-18]fluorodeoxyglucose 87
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma 87
Chest CT in patients with a moderate or high pretest probability of COVID-19 and negative swab 87
The Path to the Future: Education of Nuclear Medicine Therapeutic Specialists as Responsible Physicians 86
The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine 86
F-18-FDG PET/CT scans for children and adolescents 86
Multimodal Characterization of Supratentorial Gliomas: Relationship Among Morphological, Metabolic and Molecular features 86
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 86
Prognostic significance of molecular and imaging biomarkers in primary brain tumors 86
Evaluation of response: is F-18-FDG PET the answer? 85
PRELIMINARY-RESULTS OF PREOPERATIVE AXILLARY RADIOIMMUNOSCINTIGRAPHY WITH IN-111 B72.3 IN BREAST-CANCER 85
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients 85
Utility of gallium-67 in determining the radicality of lymph node dissections of the neck for metastatic lymph nodes with extranodal spread in patients affected by carcinoma of the head and neck 85
Assessment of mediastinal involvement in lung cancer with technetium-99m-sestamibi SPECT 84
Re: Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al. EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer. Eur Urol 2011;59:572-83 84
FDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables 84
FDG-PET as a tool to optimize residual surgery in patients with primary extragonadal germ cell tumors: preliminary results 84
Prospective evaluation of Ga-68-PSMA PET/CT in primary prostate cancer diagnosis - final results of a dedicated trial 84
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 84
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 84
[18F]FDG-PET/CT Texture Analysis in “Hot” Thyroid Nodules: Results of the validation Cohort 84
C-11-labeled methionine and evaluation of malignant pleural mesothelioma 83
PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014 83
Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: Where do we stand? 83
Pancreatic cancer or chronic pancreatitis? An answer from PET/MRI image fusion 82
Comments on the Italian Society of Endocrinology recommendations on post-surgical thyroid ablation in differentiated thyroid cancer 82
PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology 82
Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery 82
New Clinical Indications for F-18/C-11-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature 82
Prognostic and predictive role of [F-18]fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up-front pemetrexed-based chemotherapy 82
Targeted PET/TRUS software fusion‑guided biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy: A feasibility study and preliminary results 82
PET/CT radiomics in breast cancer: Mind the step 82
Radiopharmaceuticals for breast cancer imaging 81
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma 81
Axillary node metastasis detection in breast cancer with Tc-99m-sestamibi and In-111-pentetreotide 81
Standardization and quantification in PET/CT imaging: tracers beyond FDG. 80
Prone scintimammography in patients with non-palpable breast lesions 80
Nuclear medicine imaging of neuroendocrine tumours 79
Random forest analysis to predict Disease-Free Survival using FDG-PET and CT in Lung Cancer 79
Molecular Imaging in Radiotherapy Planning for Head and Neck Tumors 79
Totale 11.829
Salva come PNG Salva come JPEG
Categoria #
all - tutte 175.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 175.042
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021919 0 0 0 0 0 0 0 0 0 501 38 380
2021/20221.919 161 17 62 414 37 28 73 260 161 129 486 91
2022/20235.106 748 197 462 560 456 462 10 410 947 432 344 78
2023/20242.627 220 320 583 174 63 301 150 129 51 35 240 361
2024/20253.436 90 71 28 42 62 431 195 380 435 888 414 400
2025/202610.626 1.383 759 1.977 918 281 431 2.914 979 550 434 0 0
Totale 27.623